BiotechTube
Home/Chimeron Bio/Kevin Heyeck
KH

Kevin Heyeck

Chief Executive Officer & Board Member

Chimeron Bio

Therapeutic Areas

OncologyAutoimmune DiseasesInfectious DiseasesRare Genetic Disorders

Chimeron Bio Pipeline

DrugIndicationPhase
MultiPlex In Vivo CAR-TOncology (Cancer)Pre-clinical
Immuno-oncology Combination TherapyOncology (Cancer)Pre-clinical
mRNA Cancer VaccineOncology (Cancer)Pre-clinical
Platform Vaccine ApplicationsInfectious DiseasesDiscovery
Platform Gene Therapy ApplicationsRare Genetic DisordersDiscovery

Leadership Team at Chimeron Bio

MC
Monica Coleman
Chief Financial Officer
A(
Antonin (Tony) de Fougerolles
Board Member
AS
Afshin Safavi
Chairman of the Board
View full Chimeron Bio profile